Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis

Background/Aims Perianal fistulas are a debilitating manifestation of Crohn’s disease (CD). Despite the advent of anti-tumor necrosis factor (anti-TNF) therapy, the medical management of fistulizing CD continues to be challenged by unmet needs. We conducted a systematic review and meta-analysis of t...

Full description

Bibliographic Details
Main Authors: Fares Ayoub, Matthew Odenwald, Dejan Micic, Sushila R. Dalal, Joel Pekow, Russell D. Cohen, David T. Rubin, Atsushi Sakuraba
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2022-04-01
Series:Intestinal Research
Subjects:
vedolizumab
perianal fistula
perianal disease
crohn disease
meta-analysis
Online Access:http://www.irjournal.org/upload/pdf/ir-2021-00091.pdf

Internet

http://www.irjournal.org/upload/pdf/ir-2021-00091.pdf

Similar Items